-
Louis's Most Popular
-
Articles
Steal Some Yield and Bet on Clinical Clout With ABBV Stock
ABBV stock investors can collect dividend payments but also expect share-price upside as AbbVie continues to clear regulatory hurdles.
GameStop Gossip Makes GME Stock One to Watch
While the time to add GME stock to your portfolio, keep it on your watchlist. Shares could fall to a price where the stock's merits as a turnaround play become highly-favorable from a risk/reward standpoint. With this, the opportunity to make the stock a speculative buy could emerge.
Make a Bold Battery Bet with Albemarle (ALB) Stock
You can participate in lithium's potential upside with ALB stock, as Albemarle is a fast-growing business with .
This 100% Accurate Bull Market Indicator Just Flashed Last Week. What Now?
My friend and InvestorPlace colleague Luke Lango is also incredibly bullish on the crypto market. He expects the crypto market to enter a “boom cycle” in 2023, so he’s decided to hold a special Crypto Insider Summit with his friend and colleague Charlie Shrem on Thursday, Oct. 27, at 4 p.m. Eastern time.
Why XOM Stock Still Has Room to Run
Alongside other blue-chips that make for high-quality core portfolio holdings, be sure to include XOM stock as well.
Quant Ratings Updated on 102 Stocks
So far, this earnings season is going well. According to FactSet, 72% of S&P 500 companies that have announced have reported a positive earnings surprise and 70% of S&P 500 companies have reported a positive revenue surprise.
Why LTHM Stock Is a Lithium Play With Moonshot Potential
LTHM stock deserves a re-rating to the upside as Livent strikes a deal with a famous car manufacturer to provide battery-essential lithium.
Go for the ‘White Gold’ With SQM Stock
For deep value and hefty dividend payouts, you can jump-start your lithium-focused investments today with SQM stock.
There are Many Catalysts in the Pipeline for OXY Stock
Considering its many catalysts, OXY stock remains a great long-term holding for your portfolio.
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 102 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly.
Why SOFI Stock Is NOT a Buy Ahead of Earnings
With Q3 results not likely to change the story, continue to skip out on SOFI stock.
It’s Time to ‘Connect the Watts’ With a Stake in EVGO Stock
EVGO stock looks reasonably priced considering EVgo's rapid charging station build-out and pivot to a profitable profile.
What I Expect From the FAANG Stocks’ Earnings Next Week
The FAANG stock pack – which includes Meta Platforms, Inc. (META, which used to be the “F” as Facebook), Apple Inc. (AAPL), Amazon.com Inc. (AMZN), Netflix Inc. (NFLX), and Alphabet Inc. (GOOG) –lost their bite this year.
Everyone Is Talking about the “R” Word Again
This threat of a recession is nothing new, and it really shouldn’t surprise anybody. That’s been the biggest risk of the Federal Reserve raising key interest rates to kill inflation. If the economy slows too much, we go into a recession.
Don’t Count on a Comeback for IDEX Stock
This is a situation that stands to go from bad to worse, with little to signal big improvements are just around the corner. The best move for investors is to take a hard pass on IDEX stock.
NFLX and TSLA Report Earnings – Here’s What You Need To Know
In today’s Market 360, we are going to take a look at two highly anticipated earnings reports that were released this week: Netflix, Inc. (NFLX) and Tesla, Inc. (TSLA). I’ll also share where I expect the best earnings to come from in the quarters ahead…
Skip CVNA Stock. Carvana’s Problems Only Get Worse From Here!
As the old saying goes, don't fight the Fed - and don't fight the Fed's monetary-policy tightening, either, by holding shares of CVNA stock.
Don’t Put CareDX Stock in Your Portfolio’s Pipeline
Unfortunately, CDNA stock is a losing investment in a company with an interesting concept but poor financial execution.
